Home » FDA Cracks Down on Unapproved Diabetes Drugs
FDA Cracks Down on Unapproved Diabetes Drugs
Fifteen makers of unapproved diabetes drugs received warning letters from the FDA last week in a crackdown on products backed by questionable marketing claims and uncertain manufacturing practices. The recipients include foreign and domestic operators of both retail and Internet stores.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May